Hepatitis B surface antigen produced by a human hepatoma cell line

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Hepatitis B virus (HBV) infection is a major cause of primary liver cancer.
• Understanding the in vitro production of hepatitis B surface antigen (HBsAg) is crucial for studying HBV pathogenesis.
• The PLC/PRF/5 cell line is a human hepatoma model system.

Purpose of the Study:

• To investigate the production of HBsAg by the PLC/PRF/5 human hepatoma cell line in vitro.
• To characterize the physical and immunological properties of the produced HBsAg.
• To explore the association between HBsAg and primary liver cancer.

Main Methods:

• Culturing the PLC/PRF/5 human hepatoma cell line.
• Quantifying HBsAg in cell culture supernatant using immunological assays and a purified HBsAg standard.
• Characterizing HBsAg-associated particles using electron microscopy.
• Neutralizing immunological activity with specific antibodies to determine subtype.

Main Results:

• The PLC/PRF/5 cell line demonstrated significant in vitro production of HBsAg.
• Immunologically reactive HBsAg was detected in the supernatant, associated with 20 nm spherical particles.
• The estimated antigen production rate was 500 ng/day/10(6) cells.
• The immunological activity was neutralized by specific antibody, confirming the 'ad' subtype.

Conclusions:

• The PLC/PRF/5 cell line is a valuable model for studying in vitro HBsAg production.
• These findings contribute to understanding the relationship between HBsAg and primary liver cancer.
• Further research can utilize this model to investigate HBV-related liver disease mechanisms.